Uniform Code of Pharmaceutical Marketing Practices (UCPMP) 2024

Uniform Code of Pharmaceutical Marketing Practices (UCPMP) 2024 mind map
Recent News
Centre notifies UCPMP 2024
When
Notified on 2024-03-13
Why
To ensure transparency, integrity, and accountability in pharmaceutical marketing
To emphasize ethical practices within the sector
What
Prohibits gifts for personal benefit to healthcare professionals
Limits pecuniary benefits from pharmaceutical companies
Restricts provision of travel facilities and paid vacations
Details on
Conduct of pharmaceutical companies
Relationships with healthcare professionals
Mode of operation
Responsibilities of Pharmaceutical Associations
Constituting Ethics Committee for Pharmaceutical Marketing Practices (ECPMP)
Apex Ethics Committee for Pharmaceutical Marketing Practices (AECPMP)
Procedure for lodging and handling complaints
Penalty provisions
Promotion of drugs
Must be consistent with marketing approval
Information about drugs must be balanced, verifiable, and not misleading
Medical representatives
High standard of ethical conduct required
Prohibitions on inducements for access to healthcare professionals
Free samples
Restrictions on who can receive
Limitations on quantity and value
Where
India
Who
Ministry of Chemicals and Fertilizers
Department of Pharmaceuticals
Pharmaceutical Associations
Healthcare Professionals
Pharmaceutical Companies
Including agents, distributors, wholesalers, retailers
How
Implementation through the Department of Pharmaceuticals
Enforcement by ECPMP within each association
Compliance responsibility lies with CEOs of pharmaceutical companies
Significance
Aims to curb unethical practices in pharma industry
Promotes ethical conduct and transparency
Protects interests of patients and healthcare professionals
Challenges
Voluntary nature may impact effectiveness
Enforcement and compliance monitoring challenges
Way Forward
Consideration for legal backing to ensure compliance
Enhanced monitoring and enforcement mechanisms

The Uniform Code of Pharmaceutical Marketing Practices (UCPMP) 2024, introduced by the Ministry of Chemicals and Fertilizers, Department of Pharmaceuticals, is a regulatory framework designed to ensure transparency, integrity, and accountability in the marketing practices of the pharmaceutical industry in India. The UCPMP 2024 lays down stringent guidelines for the conduct of pharmaceutical companies and their representatives, prohibiting the provision of gifts, travel facilities, and other financial benefits to healthcare professionals for personal gain. It aims to safeguard the interests of patients and healthcare professionals by promoting ethical practices and curbing unethical behavior within the sector. The code outlines the responsibilities of pharmaceutical companies and associations in enforcing these guidelines, including the establishment of ethics committees for handling complaints and ensuring compliance​​​​​​​​.

Related Posts

Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments
X
Home Courses Plans Account